ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice

Wang, Xianfei; Sun, Kangyue; Zhou, Youlian; Wang, Hong; Zhou, Yongjian; Liu, Side; Nie, Yuqiang*; Li, Yue*广州医学院; 南方医科大学; y
Biochemical and Biophysical Research Communications2021-1-1DOI: 10.1016/j.bbrc.2020.11.009
28被引12阅读
引用收藏
分享

摘要

Aims: Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver diseases. The NOD-like receptor protein 3 (NLRP3) inflammasome was suggested to be involved in the pathogenesis of NAFLD. A small-molecule named CY-09 is a new selective and direct inhibitor of the NLRP3 inflammasome. We aimed to investigate whether CY-09 is effective for the treatment of NAFLD in a high-fat diet (HFD)-induced mouse model. @@@ Methods: Twenty mice were fed by HFD for 14 weeks, and then were randomly assigned into two groups: (1) control group receiving dimethylsulfoxide (DMSO) solution; (2) CY-09 group receiving CY-09 injection. In an 8-week follow-up, oral glucose tolerance test (OGTT) and homeostasis model assessment of insulin resistance (HOMA-IR) were used to measure glucose metabolism. Liver steatosis was evaluated by the NAFLD activity score (NAS) and deemed as the primary outcome. @@@ Results: The body weight in CY-09 group was significantly lower than the DMSO control group on 27 weeks (41.0 +/- 3.5 g vs. 49.7 +/- 5.2 g, P = 0.014). The area under the curve (AUC) of OGTT was less in CY-09 group than that in DMSO group (35.81 +/- 6.79 vs. 22.91 +/- 2.58 mmol/L.hr, P = 0.004), as well as HOMA-IR (14.36 +/- 3.89 vs. 8.82 +/- 2.04 mmol.mlU.L-2, P = 0.023). Microscopically, liver lipid droplets dramatically improved and significantly lower NAS was observed in CY-09 group (8.25 +/- 1.26 vs. 3.20 +/- 0.45, P < 0.001). @@@ Conclusion: CY-09 reduces hepatic steatosis in experimental NAFLD mice and CY-09 may be a potential therapeutic drug of NAFLD in clinical practice.

学科与关键词

关键词
NAFLDNLRP3 inflammasomeCY-09
相关
加载中…
  • Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*International Immunopharmacology, 2022, 111: 109099.被引 9
  • Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-&kappa;B/NLRP3 inflammasome-mediated hepatic inflammation in mice
    Zou, Jian; Yan, Chunyan*; Wan, Jian-Bo*Chinese Medicine, 2022, 17(1): 17.被引 13
  • Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1
    Xiang, Wenjing; Yang, Yang; Weng, Liangkun; Ye, Zhiming; Ding, Ping; Li, Huayu; Sun, Jia; Zeng, Cheng*International Immunopharmacology, 2023, 118: 110085.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical and Biophysical Research Communications
发表日期
2021-01-01
卷期
第 534 卷
页码
734-739
DOI
10.1016/j.bbrc.2020.11.009
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81600460]; Natural Science Foundation of Guangdong Province [2016A030310382]; Science and Technology Planning Project of Guangdong Province [2017A020215139]; Guangdong gastrointestinal disease research center [2017B020209003]

作者

  • W

    Wang, Xianfei (第一作者)

    guangzhou med univ

  • S

    Sun, Kangyue

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhou, Youlian

    guangzhou med univ

  • W

    Wang, Hong

    guangzhou med univ

  • Z

    Zhou, Yongjian

    guangzhou med univ

  • L

    Liu, Side

    southern med univ

  • N

    Nie, Yuqiang (通讯)

    guangzhou med univ

  • L

    Li, Yue (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417